Teladoc (TDOC) Stock Forecast & Price Target

Teladoc Health Inc. is projecting significant revenue growth in its Integrated Care segment, with a guidance of $1.613 billion in CY26, representing an increase of $34 million year-over-year. The company also anticipates a substantial rise in insurance revenue from its BetterHelp segment, forecasting between $75 million and $90 million in CY26, a notable jump from $13 million in CY25, which would elevate insurance revenue's share of BetterHelp's total revenue from 1.4% to 9.0%. Additionally, Teladoc Health's Integrated Care segment is expected to achieve an adjusted EBITDA of $251.9 million at the midpoint for CY26, marking an increase of $12.6 million year-over-year, further substantiating its strong financial trajectory and competitive market position.

Teladoc Health Inc. is facing a negative outlook primarily due to a projected decline in BetterHelp's revenue growth, which has resulted from membership reductions and rising financial uncertainty. This segment, which is anticipated to contribute a $40.5 million adjusted EBITDA headwind by CY26, is experiencing slower growth projections that undermine previous trends as management sets new targets of only low-single-digit growth. Additionally, the shift in the Integrated Care segment's revenue model from fee-based to visit-based structures, combined with fluctuations in health plan customer enrollment, exacerbates concerns regarding overall revenue stability and profitability moving forward.